dc.contributor.author |
Petousis-Harris, Helen |
en |
dc.date.accessioned |
2019-10-01T03:11:46Z |
en |
dc.date.issued |
2018-05 |
en |
dc.identifier.issn |
2164-5515 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/48203 |
en |
dc.format.medium |
Print-Electronic |
en |
dc.language |
eng |
en |
dc.relation.ispartofseries |
Human vaccines & immunotherapeutics |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.subject |
Humans |
en |
dc.subject |
Neisseria meningitidis |
en |
dc.subject |
Meningitis, Meningococcal |
en |
dc.subject |
Cross Protection |
en |
dc.title |
Author reply to VA-MENGOC-BC cross-protection (2018HV0022). |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.1080/21645515.2018.1448335 |
en |
pubs.issue |
5 |
en |
pubs.begin-page |
1069 |
en |
pubs.volume |
14 |
en |
dc.rights.holder |
Copyright: The author |
en |
pubs.publication-status |
Published |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Comment |
en |
pubs.subtype |
letter |
en |
pubs.subtype |
Journal Article |
en |
pubs.elements-id |
740515 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
Population Health |
en |
pubs.org-id |
Gen.Practice& Primary Hlthcare |
en |
dc.identifier.eissn |
2164-554X |
en |
pubs.record-created-at-source-date |
2018-04-17 |
en |
pubs.dimensions-id |
29659326 |
en |